Author:
Richardson Paul G.,Barlogie Bart,Berenson James,Singhal Seema,Jagannath Sundar,Irwin David H.,Rajkumar S. Vincent,Srkalovic Gordan,Alsina Melissa,Anderson Kenneth C.
Reference15 articles.
1. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells;Hideshima;Cancer Res.,2001
2. Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model;LeBlanc;Cancer Res.,2002
3. The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents;Ma;Clin Cancer Res.,2003
4. The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications;Mitsiades;Blood.,2003
5. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma;Jagannath;Br J Haematol.,2004
Cited by
127 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献